Abstract:Objective: To investigate the clinical effect of combination therapy with high-frequency oscillation ventilation (HFOV), pulmonary surfactant (PS) and inhaled nitric oxide (iNO) in the treatment of neonatal hypoxemic respiratory failure (HRF). Methods: A total of 116 neonates with HRF were studied, and they were randomly divided into two groups: triple therapy (n=58) and dual therapy (n=58). The triple therapy group received HFOV, PS, and iNO, while the dual therapy group received HFOV and iNO. Blood gas values, PaO2/FiO2 (P/F), oxygenation index (OI), and pulmonary arterial pressure (PA) were determined before treatment and after 24 and 48 hours of treatment. Among the neonates with different P/F ratios and OI values and with or without persistent pulmonary hypertension of the newborn (PPHN), the treatment outcomes of two groups were compared. Results: The durations of mechanical ventilation and iNO therapy in the triple therapy group were significantly shorter than in the dual therapy group (P<0.01). After 24 and 48 hours of treatment, the triple therapy group had significantly improve PaO2 and PaCO2 compared with the dual therapy group (P<0.01). After 24 and 48 hours of treatment, the neonates with PPHN in the triple therapy group had significantly decreased PA compared with the dual therapy group (P<0.01). In the cases with a P/F ratio of ≤50, the triple group had a significantly higher cure rate than the dual therapy group (P<0.05). In both groups, the P/F ratios of the neonates who died were significantly lower than those of survivors (P<0.01). In the cases with an OI of ≥40, the triple group had a significantly higher cure rate than the dual therapy group (P<0.05). In both groups, the OI values of the neonates who died were significantly higher than those of survivors (P<0.01). In neonates with PPHN, the triple group had a significantly higher cure rate than the dual therapy group (P<0.05). The triple therapy group had a significantly shorter length of hospital stay (P<0.01) and a significantly higher cure rate (P<0.05) compared with the dual therapy group. There were no significant differences in complications between the two groups (P>0.05). No severe side effect was found during the treatment in either group. Conclusions: Triple therapy with HFOV, PS and iNO is a more effective treatment for neonatal HRF compared with the dual therapy with HFOV and iNO. The triple therapy can significantly improve oxygenation and survival rate, providing a new treatment for the neonates with HRF, especially the critical cases who suffer severe lung disease with PPHN and have a P/F ratio of ≤50 or an OI of ≥40.

High Frequency Oscillatory Ventilation in Treatment of Hyaline Membrane Diseases

Clinical Efficacy of Preferred Use of High-Frequency Oscillatory Ventilation in Treatment of Neonatal Pulmonary Hemorrhage

[Use of Noninvasive High-Frequency Oscillatory Ventilation in Very Low Birth Weight Infants].

High frequency ventilation in treatment of infants with severe respiratory failure

Expired tidal volume and PaCO_2 during high frequency oscillatory ventilation in neonates

High Frequency Ventilation in the Treatment of Severe Respiratory Distress Syndrome

Application of high‐frequency oscillation ventilation combined with volume guarantee in infants with acute hypoxic respiratory failure after congenital heart surgery

Evidence-Based Medicine Study Suggestion on High Frequency Oscillatory Ventilation in Neonates

Application of High Frequency Oscillation Ventilation to Congenital Cardiac Surgery in Infants

Observations on high-frequency oscillatory ventilation effects in pediatric patients with acute respiratory distress syndrome after congenital heart surgery

High-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation plus pressure support in preterm infants with severe respiratory distress syndrome.

HFOV Vs CMV for Neonates with Moderate-to-severe Perinatal Onset Acute Respiratory Distress Syndrome (NARDS): a Propensity Score Analysis

Effect of high-frequency oscillatory ventilation on severe pulmonary injury after cardiopulmonary bypass for congenital heart disease

Comparative Study for Clinical Effect on Respiratory Failure between High Frequency Oscillatory Ventilation and Constant Frequency Ventilation in Neonates

A Prospective Randomizedcontrolled Trial of Synchronized Nasal Intermittent Positive Pressure Ventilation Intreatment of Hyaline Membrane Disease in Premature Infants

Influence of High Frequency Oscillation Ventilation to Pathological Change During Meconium Induced Lung Injury

Clinical application of high frequency oscillatory ventilation in ARDS

Hemodynamic Effects of a High-Frequency Oscillatory Ventilation Open-Lung Strategy in Critically Ill Children With Acquired or Congenital Cardiac Disease

[Clinical effect of combination therapy with high-frequency oscillation ventilation, pulmonary surfactant and inhaled nitric oxide in the treatment of neonatal hypoxemic respiratory failure]

Elective high frequency oscillatory ventilation versus conventional mechanical ventilation on the chronic lung disease or death in preterm infants administered surfactant: a systematic review and meta-analysis

A Noninvasive High Frequency Oscillation Ventilator: Achieved by Utilizing a Blower and a Valve